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Background
The PAAD Study (Probiotics for Antibiotic Associated
Diarrhoea in care homes) involves 2 stages. The first
stage is a prospective 12 month observational study to
collect data on the amount and type of antibiotic pre-
scribed episodes of Antibiotic Associated Diarrhoea and
C.difficile Associated Diarrhoea and outcome in a ran-
domly selected sample of 9 care homes. The second
stage is currently being designed but will take the form
of a RCT of probiotic vs. placebo administered alongside
the antibiotic. These two studies are governed by sepa-
rate laws and regulations in relation to mental capacity.
PAAD stage 1 is covered by the Mental Capacity Act
and, for those service users who lack capacity, personal
c o n s u l t e e sa r ea b l et og i v ea g r e e m e n tt ot h es e r v i c e
user’s participation. PAAD stage 2 is covered by the
Medicines for Human Use (Clinical Trials) Regulations
and consent is given by a personal legal representative
or a professional legal representative of the participant.
The PAAD study also presents novel challenges in rela-
tion to advanced consent. We propose to explore some
of the ethical and practical challenges of conducting
these studies (and others like it) within the care home
setting using qualitative methods. Our purpose is to
optimise the informed consent process in a vulnerable
population in preparation for stage two of PAAD.
Methods
We are conducting focus groups with staff within the 9
care homes who are participating in PAAD stage 1. We
are also conducting face-to-face interviews with service
users who have capacity, with relatives of service users,
and with GPs who provide primary care to the care
homes. Focus group and interview schedules focus on
issues such as: the merits and problems associated with
a number of models of consent for both stage one and
stage two of PAAD, views about the feasibility and
acceptability of taking advance consent/assent for
research trial procedures, and views about potentially
raising concerns about the possibility of c.difficile circu-
lating within the care home.
Results
Data collection is in early stages, and we will have data
analysed by Autumn 2011.
Conclusion
We anticipate that our data will not only optimise the
design of our informed consent process for stage 2 of
PAAD, but will also provide generalisable insights to
guide other studies which plan to conduct clinical trials
amongst vulnerable populations within care home
settings.
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